Mizuho analyst Graig Suvannavejh lowered the price target on Belite Bio, Inc, ADR (NASDAQ: BLTE) to $215.00 (from $223.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE